Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

330
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
330
Odds Ratio01:09

Odds Ratio

247
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
247
Hazard Ratio01:12

Hazard Ratio

239
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
239
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

171
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
171
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

277
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
277
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

533
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.

Heart (British Cardiac Society)·2026
Same author

Incidence and Associated Factors of Hypertension and Dyslipidemia Improvement in People With Type 2 Diabetes Remission: A Multicenter Real-World Retrospective Cohort Study (JDDM84).

Diabetes, obesity & metabolism·2026
Same author

Comparison of oncological outcomes between robotic and laparoscopic surgeries for gastric cancer: a multi-institutional cohort study in Japan.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database.

Journal of diabetes investigation·2026
Same author

Influence Analyses of "Designs" for Evaluating Inconsistency in Network Meta-Analysis.

Statistics in medicine·2026
Same author

Smartphone CBT engagement and depressive symptoms: secondary analysis of the RESiLIENT trial using a time-varying exposure approach.

Psychological medicine·2026

Related Experiment Video

Updated: Sep 6, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Risk Ratio and Risk Difference Estimation in Case-cohort Studies.

Hisashi Noma1, Munechika Misumi2, Shiro Tanaka3

  • 1Department of Data Science, The Institute of Statistical Mathematics.

Journal of Epidemiology
|June 26, 2022
PubMed
Summary

For case-cohort studies, pseudo-Poisson and pseudo-normal regression methods accurately estimate risk ratios and risk differences. These methods offer interpretable effect measures, especially when event rates are not low.

Keywords:
calibration estimatorcase-cohort studyeffect measurerare disease assumptiontwo-phase epidemiological design

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Related Experiment Videos

Last Updated: Sep 6, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Area of Science:

  • Epidemiology
  • Biostatistics

Background:

  • Ordinary logistic regression is common in case-cohort studies but odds ratios lack direct interpretation as relative risk unless event rates are low.
  • Risk ratio and risk difference are preferred measures, directly interpretable as effect measures without the rare disease assumption.

Purpose of the Study:

  • To introduce pseudo-Poisson and pseudo-normal regression for estimating risk ratios and risk differences in case-cohort studies.
  • To demonstrate improved precision of these estimators using auxiliary variable information.

Main Methods:

  • Developed pseudo-Poisson and pseudo-normal linear regression models for case-cohort data.
  • Employed inverse probability weighting for model fitting.
  • Incorporated auxiliary variable information to enhance estimator precision.

Main Results:

  • Simulations and real data analysis (National Wilms Tumor Study) confirmed accurate risk ratio and risk difference estimation.
  • Utilizing whole cohort auxiliary data significantly improved estimator precision.

Conclusions:

  • Pseudo-regression methods provide effective alternatives to logistic regression for case-cohort studies, yielding interpretable effect measures.
  • These methods are particularly valuable when dealing with higher event rates.